Methylxanthines: The Major Impact of Caffeine in Clinical Practice in Patients Diagnosed with Apnea of Prematurity
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Methylxanthines, like caffeine, effectively treat apnea of prematurity in preterm infants. This therapy reduces breathing pauses, lowers the risk of bronchopulmonary dysplasia, and improves long-term lung function.
Area Of Science
- Neonatal Medicine
- Pharmacology
- Respiratory Medicine
Background
- Apnea of prematurity affects over 85% of infants born before 34 weeks' gestation.
- Methylxanthines (caffeine, theophylline, aminophylline) are primary treatments for preterm infant apnea.
- This condition poses a significant challenge in neonatal intensive care units.
Purpose Of The Study
- To systematically review methylxanthine use for treating and preventing apnea in preterm infants.
- To evaluate the efficacy, safety, and long-term outcomes of methylxanthine therapy.
- To assess impacts on bronchopulmonary dysplasia and extubation success.
Main Methods
- Systematic review of randomized controlled trials, retrospective, and case-control studies.
- Searched PubMed, Embase, and Web of Science databases.
- Assessed risk of bias using the Cochrane Risk of Bias tool; results were narratively summarized.
Main Results
- Twenty-five studies involving 4599 preterm infants were included.
- Caffeine therapy significantly reduced bronchopulmonary dysplasia (OR 0.63) and facilitated earlier positive airway pressure discontinuation.
- Methylxanthines reduced apneic episodes, decreased bronchopulmonary dysplasia risk, aided extubation, and showed long-term pulmonary function improvements.
Conclusions
- Methylxanthines, particularly caffeine, are evidence-based for apnea of prematurity.
- Benefits extend beyond apnea reduction to include decreased bronchopulmonary dysplasia and reduced mechanical ventilation needs.
- Limitations include study heterogeneity and reliance on the CAP trial for key findings.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...